FLT1 and melanoma: Moreover, we have investigated the influence of VEGFR‐1 silencing on chemosensitivity to vemurafenib in M14‐VR melanoma cells, where acquisition of resistance to the BRAFi resulted in induction of the receptor that was instead absent in the parental cells.